- Home
- BCRX vs HLIO Comparison
BCRX vs HLIO Comparison
Compare BCRX & HLIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCRX | HLIO |
|---|---|---|
| Founded | 1986 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 1995 | 1996 |
Fundamental Metrics
Financial Performance| Metric | BCRX | HLIO |
|---|---|---|
| Price | $8.51 | $66.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 6 |
| Target Price | $20.82 | ★ $65.50 |
| AVG Volume (30 Days) | ★ 4.2M | 317.9K |
| Earning Date | 05-15-2026 | 06-02-2026 |
| Dividend Yield | N/A | ★ 0.55% |
| EPS Growth | ★ 381.40 | 23.93 |
| EPS | 1.21 | ★ 1.45 |
| Revenue | $25,186,000.00 | ★ $200,727,000.00 |
| Revenue This Year | N/A | $1.86 |
| Revenue Next Year | $12.55 | $5.05 |
| P/E Ratio | ★ $7.23 | $45.39 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.00 | $24.76 |
| 52 Week High | $11.31 | $76.47 |
Technical Indicators
Market Signals| Indicator | BCRX | HLIO |
|---|---|---|
| Relative Strength Index (RSI) | 63.78 | 41.84 |
| Support Level | $7.95 | $50.57 |
| Resistance Level | $8.68 | $68.56 |
| Average True Range (ATR) | 0.31 | 3.15 |
| MACD | 0.05 | -1.28 |
| Stochastic Oscillator | 70.43 | 26.13 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About HLIO Helios Technologies Inc.
Helios Technologies Inc is a industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic cartridge valves, hydraulic quick release couplings as well as engineers complete hydraulic systems. The Electronics segment designs and manufactures customized electronic controls systems and displays for a variety of end markets including industrial and mobile, recreational and health and wellness. It derives maximum revenue from the Hydraulics Segment.